AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 121 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,385,000 | +187.3% | 113,798 | +172.7% | 0.04% | +216.7% |
| Q3 2019 | $482,000 | -59.3% | 41,734 | -46.5% | 0.01% | -61.3% |
| Q4 2018 | $1,184,000 | +78.3% | 77,942 | +136.4% | 0.03% | +121.4% |
| Q3 2018 | $664,000 | -70.2% | 32,967 | -70.2% | 0.01% | -67.4% |
| Q2 2018 | $2,231,000 | +50.2% | 110,604 | +50.1% | 0.04% | +38.7% |
| Q1 2018 | $1,485,000 | +13.9% | 73,681 | -24.0% | 0.03% | +10.7% |
| Q4 2017 | $1,304,000 | -30.4% | 96,916 | -5.1% | 0.03% | -22.2% |
| Q3 2017 | $1,873,000 | -28.9% | 102,160 | -28.6% | 0.04% | -30.8% |
| Q2 2017 | $2,633,000 | -41.6% | 143,107 | -28.4% | 0.05% | -52.7% |
| Q1 2017 | $4,507,000 | +19.6% | 199,868 | +84.6% | 0.11% | -17.9% |
| Q4 2016 | $3,768,000 | -36.5% | 108,280 | -55.3% | 0.13% | -26.8% |
| Q3 2016 | $5,935,000 | +40.4% | 242,166 | +37.0% | 0.18% | +31.7% |
| Q2 2016 | $4,228,000 | -18.6% | 176,742 | -20.4% | 0.14% | -6.7% |
| Q1 2016 | $5,197,000 | +37.7% | 222,089 | +77.6% | 0.15% | +67.4% |
| Q4 2015 | $3,774,000 | – | 125,021 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |